Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with ...

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

Why one man — and others in his gray market community — is making tirzepatide at home. Insurance wouldn't cover his weight loss medication. So he started making his own.

Shady drugmaker used code words to sell knockoff weight-loss drug: Lawsuit After cease-and-desist letter, Pivotal Peptides allegedly sold mix-your-own tirzepatide as "11 mg." ...

Overall, the study found that tirzepatide was more effective at helping participants lose weight. About 82% of participants taking tirzepatide experienced 5% or greater weight loss.

Any use of tirzepatide jumped to 12.3% of all GLM use by December 2023, while SGLT2 inhibitor and GLP-1 RA use rose from 14.5% to 24.4% and 19.5% to 28.5%, respectively, between January 2021 and ...

Sharp increases were seen in dispensations of tirzepatide (0.0 to 40.6%) and semaglutide (2.4 mg; 0.0 to 32.2%) among adults without diabetes but prescribed WLMs; the most frequently dispensed WLM ...

Adults with overweight or obesity lost more weight with the GIP/GLP-1 dual agonist tirzepatide than the GLP-1 receptor agonist semaglutide, according to findings published in JAMA Internal Medicine.